About Endomag
Endomag is a Healthcare company based in Cambridge (United Kingdom) founded in 2007, and was acquired by Hologic in April 2024. Developer of a device for tumor localization. Endomag has raised $44.52 million across 9 funding rounds from investors including Gov.uk, Hologic and Draper Esprit. Endomag was last valued at $117.66 million in November 2020. Its website endomag.com draws about 11 thousand monthly visits. Endomag offers products and services including Sentimag, MagseedPro, Magseed, and Magtrace. Its focus areas include Life Sciences, Oncology, Medical Devices and Surgical Tools. Its legal entity is ENDOMAGNETICS LTD.
Company details
Endomagnetics has developed a device for tumor identification and detection. The company has developed devices that are Sentimag, a tumor localization system, Magseed markers to localize breast cancer during surgery, and Magtrace lymphatic tracer uses tiny magnetic particles for radiation-free sentinel lymph node biopsies.
- Headquarters Cambridge, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website endomag.com
- Social LinkedIn X
- Acquired by Hologic (Apr 2024)
- Legal Name Endomagnetics Ltd
- Date of Incorporation 26 Apr, 2007
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
Products & Services of Endomag
Endomag offers a comprehensive portfolio of products and services, including Sentimag, MagseedPro, Magseed, and Magtrace.
Provides magnetic guidance for breast cancer surgery to enhance precision.
Advanced marker for accurate tumor localization in procedures.
Seed device for identifying breast cancer sites during surgery.
Simple tool for breast cancer staging and treatment planning.
Funding Insights of Endomag
Endomag has successfully raised a total of $44.52M across 9 strategic funding rounds. The most recent funding activity was a Series D round of $20.7 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $44.52M
- Total Rounds 9
- Last Round Series D — $20.7M
- First Round $577,000
(Jun 2009)
- Investors Count 3
All 9 funding rounds of Endomag with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | $20.7M | Series D | $117.66M | Draper Esprit | |
| Jul 2018 | $10.5M | Series C | $41.6M | Draper Esprit | – |
| Feb 2018 | Grant | – | – | ||
| Aug 2016 | $2.2M | Series A | $••••• | – | – |
| Jun 2014 | $3.7M | Series A | $••••• | – | – |
| Jul 2013 | $3.3M | Seed | $••••• | – | – |
| Aug 2011 | $3M | Seed | $••••• | – | – |
| Sep 2010 | $539,000 | Seed | $••••• | – | – |
| Jun 2009 | $577,000 | Seed | $••••• | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Nov 2020 | $117.66M | •••••••• |
| Jul 2018 | $41.6M | •••••••• |
| Aug 2016 | $••••• | •••••••• |
| Jun 2014 | $••••• | •••••••• |
| Jul 2013 | $••••• | •••••••• |
| Aug 2011 | $••••• | •••••••• |
| Sep 2010 | $••••• | •••••••• |
| Jun 2009 | $••••• | •••••••• |
Full valuation and stage history of Endomag
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $117.66M (Nov 2020). 4 investors in total: 4 institutional.
Investors in Endomag
Endomag has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, Hologic and Draper Esprit.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Stage agnostic VC firm investing globally | 2004 | draperesprit.com | London, United Kingdom | |
Early-stage venture capital investments are made by Sussex Place Ventures. | spventures.com | London, United Kingdom | ||
Online government services and information are provided to users. | 1707 | gov.uk | London, United Kingdom | |
Diagnostic and surgical products for women's healthcare are provided. | 1985 | hologic.com | Marlborough, United States |
Investor details for Endomag
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Endomag
24 people are tracked at Endomag (6 in leadership, 2 in board & advisors, 16 in team).
| Name | Role | Group |
|---|---|---|
Stuart Devine | Chief Commercial Officer | Leadership |
Eric Mayes | General Manager | Leadership |
Martin Leckie | Sales Director (uk & Ire) | Leadership |
Dan Sturt | Market Development Director | Leadership |
Mehryar Behizad | Regulatory Director | Leadership |
Sauvanee Gan | Customer Care Director | Leadership |
John Brimacombe | Director | Board & advisors |
Peter Keen | Non-Executive Director | Board & advisors |
James Jabarian | Strategic Account Manager | Team |
Lucy French | Digital And Marketing Operations Manager | Team |
Audrey Ernst | Strategic Account Manager | Team |
Teller Sven | Stratigic Account Manager | Team |
Paul Stewart | International Market Development Manager | Team |
Melanie Roth | Strategischer Account-manager | Team |
Joel Abraham | Sales Operation Lead | Team |
Kate Male | Customer Care Specialist | Team |
Anna Andreàsson | Strategic Account Manager | Team |
Steve Mure | Global Training Manager | Team |
Helene E. | Customer Care Specialist | Team |
Shabnaz Hussain | Office Administrator | Team |
4 more people are available in the full profile.
Complete people profiles for Endomag
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Endomag
5 dated milestones of Endomag across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Endomag is founded.
- Funding First funding round of $577K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series D, of $20.7M.
- Exit Acquired by Hologic.
Web traffic of Endomag
The website of Endomag (endomag.com) receives about 10.7K visits a month.
- Monthly visits10.7K
▲ 23.3% vs previous month
Websites whose visitors overlap most with Endomag. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| giblib.com | 27% | 23K | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Endomag
Complete news archive for Endomag
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endomag
Endomag was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Endomag is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Endomag is a funded company, having raised a total of $44.52M across 9 funding rounds to date. The company's 1st funding round was a Seed of $577K, raised on Jun 2009.
Annual revenue of Endomag is $22.58M as on Dec 31, 2022.
Endomagnetics has developed a device for tumor identification and detection. The company has developed devices that are Sentimag, a tumor localization system, Magseed markers to localize breast cancer during surgery, and Magtrace lymphatic tracer uses tiny magnetic particles for radiation-free sentinel lymph node biopsies.
Endomag offers Sentimag, MagseedPro, Magseed, and Magtrace.
Endomag has 4 investors. Key investors include Gov.uk, Hologic, Draper Esprit, and Sussex Place Ventures.
The valuation of Endomag is $117.66M as of Nov 2020.
Endomag operates through Endomagnetics Ltd.
Yes. Endomag was acquired by Hologic in April 2024.